Bioprocessing technology has a role to play in helping developers exert greater control over production processes.

For CRISPR Therapeutics specifically, that financial flexibility is not necessarily needed even if it's a plus. As of the most recent quarter, Q3, it reported having around $1.9 billion in cash, ...

According to latest data from National cancer registry, the estimated number of incident cases of cancer in India in 2022 was ...

As the founder and CEO of Immunocine Cancer Center, based in Cancún, Mexico, he has transformed his vision into reality with ...

Combining phototherapy with chemotherapy may provide a more powerful approach to combat aggressive tumors effectively.

PHILADELPHIA, PA — Vittoria Biotherapeutics, Inc. has announced the launch of its Phase 1 clinical trial for VIPER-101, a ...

Reaching the end of a long road to approval, the first mesenchymal stromal cell (MSC) therapy for steroid-refractory acute ...

The new, long-term lease includes an immediate $12 million capital investment in facility upgrades, equipment and business ...

"BrightPath and Cellistic partner for clinical trial advancements of CAR-T cell therapy" was originally created and published ...

A lengthy treatment process, coupled with weighty risks for recipients to consider, has resulted in plodding adoption of ...

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science ...

The most-read gene therapy articles included topics on FDA approvals, chimeric antigen receptor T-cell therapies, the ...